Home > Qtrly Results > MANKIND PHARMA

MANKIND PHARMA
Quarterly Results Analysis [Mar2025]

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹3,079 Cr ₹3,230 Cr ₹3,077 Cr ₹2,893 Cr ₹2,422 Cr ₹2,607 Cr ₹2,708 Cr ₹2,579 Cr
Expenses ₹2,396 Cr ₹2,400 Cr ₹2,226 Cr ₹2,212 Cr ₹1,836 Cr ₹2,000 Cr ₹2,025 Cr ₹1,924 Cr
Operating Income ₹683 Cr ₹830 Cr ₹850 Cr ₹682 Cr ₹586 Cr ₹607 Cr ₹683 Cr ₹655 Cr
Other Income ₹251 Cr ₹77 Cr ₹109 Cr ₹101 Cr ₹92 Cr ₹70 Cr ₹60 Cr ₹59 Cr
Interest ₹191 Cr ₹221 Cr ₹7 Cr ₹11 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹6 Cr
Depreciation ₹231 Cr ₹192 Cr ₹106 Cr ₹108 Cr ₹100 Cr ₹110 Cr ₹96 Cr ₹87 Cr
Profit Before Tax ₹513 Cr ₹494 Cr ₹847 Cr ₹664 Cr ₹570 Cr ₹558 Cr ₹638 Cr ₹620 Cr
Profit After Tax ₹427 Cr ₹381 Cr ₹656 Cr ₹539 Cr ₹475 Cr ₹455 Cr ₹508 Cr ₹489 Cr
EPS ₹10.20 ₹9.22 ₹16.31 ₹13.39 ₹11.76 ₹11.33 ₹12.51 ₹12.15
Industry Peers & Returns1W1M1Y
MANKIND PHARMA 0.2% -2.4% 12.5%
SUN PHARMACEUTICAL INDUSTRIES 1.6% -2.9% 17.2%
DIVIS LABORATORIES 1.5% 10.4% 51.9%
CIPLA 2.3% 1.9% 2.8%
TORRENT PHARMACEUTICALS 1.4% 1.3% 17%
DR REDDYS LABORATORIES 5.7% 14.1% 15.2%
ZYDUS LIFESCIENCES 5.1% 10.9% -4.4%
LUPIN 2% -2.2% 27.9%
AUROBINDO PHARMA 1.5% -0.2% -3.3%

MANKIND PHARMA Quarterly Revenues

Revenues
Q-o-Q

-4.66 %

Y-o-Y

27.13 %

Quarters Revenues % Change
Mar2025 ₹3,079 Cr
-4.66
Dec2024 ₹3,230 Cr
4.99
Sep2024 ₹3,077 Cr
6.33
Jun2024 ₹2,893 Cr
19.45
Mar2024 ₹2,422 Cr
-7.09
Dec2023 ₹2,607 Cr
-3.74
Sep2023 ₹2,708 Cr
5.02
Jun2023 ₹2,579 Cr -

MANKIND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-17.67 %

Y-o-Y

16.53 %

Quarters Operating Profit % Change
Mar2025 ₹683 Cr
-17.67
Dec2024 ₹830 Cr
-2.38
Sep2024 ₹850 Cr
24.68
Jun2024 ₹682 Cr
16.28
Mar2024 ₹586 Cr
-3.33
Dec2023 ₹607 Cr
-11.16
Sep2023 ₹683 Cr
4.25
Jun2023 ₹655 Cr -
Operating Margins
Q-o-Q

-13.62 %

Y-o-Y

-8.31 %

Quarters Operating Margin% % Change
Mar2025 22.19%
-13.62
Dec2024 25.69%
-7.02
Sep2024 27.63%
17.28
Jun2024 23.56%
-2.64
Mar2024 24.2%
4.04
Dec2023 23.26%
-7.74
Sep2023 25.21%
-0.71
Jun2023 25.39% -

MANKIND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

11.96 %

Y-o-Y

-10.08 %

Quarters Profit After Tax % Change
Mar2025 ₹427 Cr
11.96
Dec2024 ₹381 Cr
-41.94
Sep2024 ₹656 Cr
21.73
Jun2024 ₹539 Cr
13.62
Mar2024 ₹475 Cr
4.24
Dec2023 ₹455 Cr
-10.34
Sep2023 ₹508 Cr
3.73
Jun2023 ₹489 Cr -
PAT Margins
Q-o-Q

17.46 %

Y-o-Y

-29.25 %

Quarters PAT Margin(%) % Change
Mar2025 13.86 %
17.46
Dec2024 11.8 %
-44.68
Sep2024 21.33 %
14.49
Jun2024 18.63 %
-4.90
Mar2024 19.59 %
12.20
Dec2023 17.46 %
-6.88
Sep2023 18.75 %
-1.21
Jun2023 18.98 % -

MANKIND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

10.63 %

Y-o-Y

-13.27 %

Quarters EPS % Change
Mar2025 ₹10.2
10.63
Dec2024 ₹9.22
-43.47
Sep2024 ₹16.31
21.81
Jun2024 ₹13.39
13.86
Mar2024 ₹11.76
3.80
Dec2023 ₹11.33
-9.43
Sep2023 ₹12.51
2.96
Jun2023 ₹12.15 -

You may also like the below Video Courses